aniline

Clc1ccnc(Nc2ccccc2)c1
Reaction #161
Ausbeute 55.8%750 AstraZeneca ELN dataset
Clc1ccc(Nc2ccccc2)c(Cl)n1
Reaction #243
Ausbeute 0.0%750 AstraZeneca ELN dataset
Clc1ccc(Nc2ccccc2)c(Cl)n1
Reaction #252
Ausbeute 0.0%750 AstraZeneca ELN dataset
Clc1ccc(Nc2ccccc2)c(Cl)n1
Reaction #253
Ausbeute 0.0%750 AstraZeneca ELN dataset
Clc1ccc(Nc2ccccc2)c(Cl)n1
Reaction #254
Ausbeute 92.1%750 AstraZeneca ELN dataset
O=[N+]([O-])c1ccccc1Nc1ccccc1
Reaction #498
Ausbeute 84.9%750 AstraZeneca ELN dataset
COC(=O)c1cc(Br)cc(Nc2ccccc2)c1
Reaction #577
Ausbeute 0.0%750 AstraZeneca ELN dataset
COC(=O)c1cc(Nc2ccccc2)cc(B2OC(C)(C)C(C)(C)O2)c1
Reaction #597
Ausbeute 2.3%750 AstraZeneca ELN dataset
COC(=O)c1cc(Nc2ccccc2)cc(B2OC(C)(C)C(C)(C)O2)c1
Reaction #598
Ausbeute 0.0%750 AstraZeneca ELN dataset
COC(=O)c1cc(Br)cc(Nc2ccccc2)c1
Reaction #620
Ausbeute 40.5%750 AstraZeneca ELN dataset
c1ccc(Nc2ccncc2)cc1
Reaction #667
Ausbeute 24.9%750 AstraZeneca ELN dataset
c1ccc(Nc2ccncc2)cc1
Reaction #668
Ausbeute 40.9%750 AstraZeneca ELN dataset
c1ccc(Nc2ccncc2)cc1
Reaction #669
Ausbeute 20.3%750 AstraZeneca ELN dataset
Clc1cccc(Nc2ccccc2)n1
Reaction #734
Ausbeute 53.0%750 AstraZeneca ELN dataset
CNC(=O)c1cc(Cl)nc(Nc2ccccc2)c1
Reaction #746
Ausbeute 52.9%750 AstraZeneca ELN dataset
O=C(CBr)Nc1ccccc1
Reaction #1059
N-phenyl-2-bromoacetamide
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
O=C(Nc1ccccc1)c1ccc([N+](=O)[O-])cc1
Reaction #2522
title compound
Ausbeute 97.5%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
O=C(Nc1ccccc1)c1cccc([N+](=O)[O-])c1
Reaction #2535
title compound
Ausbeute 78.2%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21
Reaction #3289
6-(2,6-Dichlorophenyl)-8-methyl-2-phenylamino-8H-pyrido[2,3-d]pyrimidin-7-one
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
CCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21
Reaction #3297
6-(2,6-Dichlorophenyl)-8-ethyl-2-phenylamino-8H-pyrido[2,3-d]pyrimidin-7-one
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
Seite 1Weiter